Abstract
Skin cancer is common. General practitioners, general surgeons, dermatologists, and plastic surgeons all play a role in the management of cutaneous malignancies. Because patients are in contact with their primary care physicians more frequently, primary care physicians are instrumental in early detection and non-surgical management. Additionally, patient survival is statistically improved when a dermatologist is involved in patient care. Significant overlap in scope of practice exists, particularly between plastic surgeons and dermatologists. Either specialty may perform wide local excision or Mohs microsurgery as the definitive surgical management for skin cancers. A review of reconstructive challenges by region may act as a guide for which cases may ultimately require the expertise of a reconstructive surgeon.
Keywords: Dermatology, plastic surgery, primary care, reconstruction, skin, surgery.
Graphical Abstract
Current Cancer Therapy Reviews
Title:Managing Skin Malignancies- How Family Doctors, Plastic Surgeons, and Dermatologists Can Help
Volume: 12 Issue: 3
Author(s): A. Steve, P. Chang, P. Tai, T. Bradel and E. Yu
Affiliation:
Keywords: Dermatology, plastic surgery, primary care, reconstruction, skin, surgery.
Abstract: Skin cancer is common. General practitioners, general surgeons, dermatologists, and plastic surgeons all play a role in the management of cutaneous malignancies. Because patients are in contact with their primary care physicians more frequently, primary care physicians are instrumental in early detection and non-surgical management. Additionally, patient survival is statistically improved when a dermatologist is involved in patient care. Significant overlap in scope of practice exists, particularly between plastic surgeons and dermatologists. Either specialty may perform wide local excision or Mohs microsurgery as the definitive surgical management for skin cancers. A review of reconstructive challenges by region may act as a guide for which cases may ultimately require the expertise of a reconstructive surgeon.
Export Options
About this article
Cite this article as:
Steve A., Chang P., Tai P., Bradel T. and Yu E., Managing Skin Malignancies- How Family Doctors, Plastic Surgeons, and Dermatologists Can Help, Current Cancer Therapy Reviews 2016; 12 (3) . https://dx.doi.org/10.2174/1573394713666161227124604
DOI https://dx.doi.org/10.2174/1573394713666161227124604 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Advancement of Human Serum Albumin-Based Molecular Probes for Molecular Imaging
Current Pharmaceutical Design Dietary Phytochemicals in Chemoprevention of Cancer
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung Adenocarcinoma
Current Cancer Drug Targets Mitochondria in Cancer Stem Cells: A Target for Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies
Current Signal Transduction Therapy Current Treatment of Psoriasis with Biologics
Current Drug Discovery Technologies Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets Low Doses Naltrexone: The Potential Benefit Effects for its Use in Patients with Cancer
Current Drug Research Reviews Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer
Current Cancer Drug Targets Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models
Current Cancer Drug Targets Disintegrins from Snake Venoms and their Applications in Cancer Research and Therapy
Current Protein & Peptide Science Tyrosine Kinases as New Molecular Targets in Treatment of Inflammatory Disorders and Leukemia
Current Pharmaceutical Design VEGF Inhibitors in Cancer Therapy
Current Pharmaceutical Design Recent Advances on Radionuclide Labeled Hypoxia-Imaging Agents
Current Pharmaceutical Design Regulation of Apoptosis and Cell Survival by Resveratrol
Mini-Reviews in Organic Chemistry Vitamin D Receptor Signaling and Pancreatic Cancer Cell EMT
Current Pharmaceutical Design Bortezomib Targets the Caspase-Like Proteasome Activity in Cervical Cancer Cells, Triggering Apoptosis That Can be Enhanced by Nelfinavir
Current Cancer Drug Targets Nanotechnology: A Modern Contraption in Cosmetics and Dermatology
Applied Clinical Research, Clinical Trials and Regulatory Affairs